HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

Ivonne Haffner; Katrin Schierle; Elba Raimundez; Birgitta Geier; Dieter Maier; Jan Hasenauer; Birgit Luber; Axel Walch; Katharina Kolbe; Jorge Riera Knorrenschild; Albrecht Kretzschmar; Beate Rau; Ludwig Fischer von Weikersthal; Miriam Ahlborn; Gabriele Siegler; Stefan Fuxius; Thomas Decker; Christian Wittekind; Florian Lordick

doi:10.1200/JCO.20.02761

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

Ivonne Haffner, Katrin Schierle, Elba Raimundez, Birgitta Geier, Dieter Maier, Jan Hasenauer, Birgit Luber, Axel Walch, Katharina Kolbe, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Beate Rau, Ludwig Fischer von Weikersthal, Miriam Ahlborn, Gabriele Siegler, Stefan Fuxius, Thomas Decker, Christian Wittekind, Florian Lordick

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

70 Quellenangaben (Web of Science)

Originalsprache	undefiniert/unbekannt
Fachzeitschrift	Journal of Clinical Oncology
DOIs	https://doi.org/10.1200/JCO.20.02761
Publikationsstatus	Veröffentlicht - 2021

Zugriff auf Dokument

10.1200/JCO.20.02761

Andere Dateien und Links

https://publons.com/wos-op/publon/45519571/

Dieses zitieren

Haffner, I., Schierle, K., Raimundez, E., Geier, B., Maier, D., Hasenauer, J., Luber, B., Walch, A., Kolbe, K., Riera Knorrenschild, J., Kretzschmar, A., Rau, B., von Weikersthal, L. F., Ahlborn, M., Siegler, G., Fuxius, S., Decker, T., Wittekind, C., & Lordick, F. (2021). HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.20.02761

@article{1a1ccef4ad7541058eeb8cc437336f3c,

title = "HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study",

author = "Ivonne Haffner and Katrin Schierle and Elba Raimundez and Birgitta Geier and Dieter Maier and Jan Hasenauer and Birgit Luber and Axel Walch and Katharina Kolbe and {Riera Knorrenschild}, Jorge and Albrecht Kretzschmar and Beate Rau and {von Weikersthal}, {Ludwig Fischer} and Miriam Ahlborn and Gabriele Siegler and Stefan Fuxius and Thomas Decker and Christian Wittekind and Florian Lordick",

year = "2021",

doi = "10.1200/JCO.20.02761",

language = "Undefined/Unknown",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

}

Haffner, I, Schierle, K, Raimundez, E, Geier, B, Maier, D, Hasenauer, J, Luber, B, Walch, A, Kolbe, K, Riera Knorrenschild, J, Kretzschmar, A, Rau, B, von Weikersthal, LF, Ahlborn, M, Siegler, G, Fuxius, S, Decker, T, Wittekind, C & Lordick, F 2021, 'HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study', Journal of Clinical Oncology. https://doi.org/10.1200/JCO.20.02761

TY - JOUR

T1 - HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

AU - Haffner, Ivonne

AU - Schierle, Katrin

AU - Raimundez, Elba

AU - Geier, Birgitta

AU - Maier, Dieter

AU - Hasenauer, Jan

AU - Luber, Birgit

AU - Walch, Axel

AU - Kolbe, Katharina

AU - Riera Knorrenschild, Jorge

AU - Kretzschmar, Albrecht

AU - Rau, Beate

AU - von Weikersthal, Ludwig Fischer

AU - Ahlborn, Miriam

AU - Siegler, Gabriele

AU - Fuxius, Stefan

AU - Decker, Thomas

AU - Wittekind, Christian

AU - Lordick, Florian

PY - 2021

Y1 - 2021

UR - https://publons.com/wos-op/publon/45519571/

U2 - 10.1200/JCO.20.02761

DO - 10.1200/JCO.20.02761

M3 - Originalarbeit

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -